1-4 of 4
Lydia Sanchez-Verde
Close
Sort by
Journal Articles

SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms

Brief Report
Santiago Montes-Moreno, Rocio Ramos-Medina, Azahara Martínez-López, Carlos Barrionuevo Cornejo, Alejandro Parra Cubillos, Shirley Quintana-Truyenque, Socorro María Rodriguez Pinilla, Raquel Pajares, Lydia Sanchez-Verde, Jorge Martinez-Torrecuadrada, Giovanna Roncador, Miguel Angel Piris
Journal: Blood
Blood (2013) 121 (4): 643–647.
https://doi.org/10.1182/blood-2012-08-447599
Published: 2013
Includes: Supplemental data
Journal Articles

Several Immune Cell Subsets Are Associated with Outcome in the Microenvironment of Follicular Lymphoma.

Björn Engelbrekt Wahlin, Mohit Aggarwal, Santiago Montes-Moreno, Luis Francisco Gonzalez, Giovanna Roncador, Lydia Sanchez-Verde, Birger Christensson, Birgitta Sander, Eva Kimby
Journal: Blood
Blood (2009) 114 (22): 3953.
https://doi.org/10.1182/blood.V114.22.3953.3953
Published: 2009
Journal Articles

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

Santiago Montes-Moreno, Giovanna Roncador, Lorena Maestre, Nerea Martínez, Lydia Sanchez-Verde, Francisca I. Camacho, Jimena Cannata, Jorge L. Martinez-Torrecuadrada, Yulei Shen, Wing C. Chan, Miguel A. Piris
Journal: Blood
Blood (2008) 111 (1): 351–358.
https://doi.org/10.1182/blood-2007-06-094151
Published: 2008
Journal Articles

Follicular Lymphoma: Design of a Protein-Based Survival Predictor Using Tissue-Microarrays (TMA).

Francisca I. Camacho, MD, Reyes Arranz-Saez, MD, Alessia Caleo, MD, Jimena Cannata, MD, Laura Cereceda, Leocricia Gonzalez, MD, Mª Elena Perez-Martin, MD, Lydia Sanchez-Verde, PhD, Carlos Montalban, MD, Juan F. Garcia, MD, Miguel A. Piris, MD, Carmen Bellas, PhD
Journal: Blood
Blood (2004) 104 (11): 2266.
https://doi.org/10.1182/blood.V104.11.2266.2266
Published: 2004